Rehydra+ Review: Six Months, No Way Out

Rehydra+ Wellness sells compounded GLP-1, a broad peptide shelf, NAD+ and testosterone out of an ordinary web store. We screened it in August 2026 alongside six other telehealth sellers. Its regulatory record came back clean. We would still tell most readers to walk away, and this review exists to explain exactly why rather than to leave the company uncovered — an unreviewed provider is one a reader meets for the first time at checkout.

The term this review turns on

Every GLP-1 membership Rehydra+ sells is valid for six months and explicitly non-cancelable. That phrase is the company's own, and it appears on two independent surfaces: the memberships page and each individual product page.¹

Which means the advertised monthly rate is not a rate. It is a sixth of a contract:

Semaglutide Tier 1 advertises $119 a month. The minimum purchase is $714. Tier 2 advertises $169; the minimum is $1,014. Tier 3 advertises $229; the minimum is $1,374. On tirzepatide, Tier 1 advertises $169 for a minimum of $1,014, Tier 2 advertises $289 for a minimum of $1,734, and Tier 3 advertises $419 for a minimum of $2,514.¹

There is no month-to-month membership rung anywhere on the site. So "Rehydra+ from $119 a month" describes a price nobody can buy for one month, and a reader who signs up intending to try it and stop has committed to at least $714 before the first vial ships.

Reading the cancellation terms before you pay is step seven of our provider checklist, and this is the clearest illustration of why the step exists. A meaningful share of people stop GLP-1 treatment in the first two months, sometimes because of nausea and sometimes because of something that needs stopping fast — the warning signs in gallbladder and pancreatitis risk are exactly the situation where you want an exit rather than a contract. Rehydra+ sells you the medication and keeps the exit.

What you can buy without signing

The one cancel-anytime purchase here is a one-time supply pack, priced by weekly dose and by how much medication comes in the box.

Semaglutide runs $149 for four weeks at 0.25 mg, $179 at 0.5 mg, $199 at 1.0 mg, $269 at 1.7 mg and $289 at 2.5 mg. Eight-week packs run from $269 to $499, and twelve-week packs from $399 to $749. Tirzepatide runs $219 for four weeks at 2.5 mg, $249 at 5 mg, $319 at 7.5 mg, $449 at 10 mg, $629 at 12.5 mg and $649 at 15 mg; eight weeks costs $379 to $939, and twelve weeks $569 to $1,419, with no twelve-week option at the 10 mg or 12.5 mg doses.²

Note the unit carefully, because it is the trap sitting underneath the good news. "Duration" here is supply length, not a billing cadence. A four-week pack is the smallest thing you can put in the basket; buying one is a purchase, not an enrolment, and $149 for four weeks at the starting dose is a fair number by the standards of what compounded GLP-1 costs per month.

The catalogue is the second problem

Rehydra+ sells testosterone as a normal cart item at $399 for ten weeks. It sells BPC-157 from $320, a BPC-157 and TB-500 stack from $380, KPV from $320, sermorelin from $250, tesamorelin from $399, GHK-Cu from $220, MOTS-c at $399, two blend products at $299 and $399, NAD+ from $279, and a lipotropic injection from $149.

Two things about that shelf. First, Rehydra+ sells BPC-157, KPV and tesamorelin in oral form as well as injectable, and oral bioavailability for those peptides is not established — selling a route whose absorption has not been demonstrated is a decision that tells you how this operator evaluates its own catalogue. Second, that peptide set is the same restricted-compound group now sitting under active federal compounding review, which is the ground the end of GLP-1 compounding covers and the reason this site is not building buying guides around any of it.

What the site will not tell you

The pharmacy is never named. You get "our pharmacy partner", which is not a disclosure.

Three clinicians are named — John H. Hamilton, MD as medical director, Angie Tuzson, NP, and Jared Folwell, MD — and none of them publishes an NPI, so none can be checked against the national registry. That is a straightforward, free check when the number is published, as it is at The Edit; here there is nothing to check.

The About page says the company serves patients in 20 states. Those 20 states are never listed. The only state list anywhere on the site is a checkout dropdown containing all 50, which is a form field, not a served-states disclosure.

Rehydra+ also claims a third-party certification in prose. On sites where that certification is genuine, the badge is served from the certifying body's own image host and carries a unique seal identifier. Here it is an image file hosted in the site's own uploads folder, linking to a keyword search rather than to a certificate, with no seal ID anywhere. We could not verify the claim. We are recording it as unverified — not as false, which is a different accusation and one we are not making. But the whole point of a certification badge is that a stranger can check it, and this one cannot be checked.

Financing runs through a buy-now-pay-later provider, with a 2.99 percent processing fee on credit-card down payments disclosed only on the payment-plan page. Prescription and compounded medications are not returnable or refundable once shipped. And because this is a shop rather than a consultation, you pay before any provider reviews you — the refund policy does not clearly say what happens if you are then declined.

The legal entity is given as RealHealth Ventures PLLS, doing business as Rehydra+ Wellness, at a San Antonio, Texas address. "PLLS" is how the site spells it; we are recording it verbatim.

The screen it passed

The trading name and the legal entity both returned zero company-column matches in the FDA's live warning-letter index.³ The pass carried a positive control — an unrelated telehealth seller with a real February 2026 letter — which returned correctly every time, so that zero is evidence rather than a query that silently failed.

We are saying that plainly because it is true and because it is not the question this review turns on. Nothing about a six-month non-cancelable membership is unlawful. That is precisely why the reader has to catch it, and why a regulator's silence is not a substitute for reading the terms.

The ruling

Buy the one-time packs or buy nothing. If you want compounded semaglutide from Rehydra+ and you have understood that a membership is a six-month commitment with no exit, the supply packs are a legitimate way to transact and $149 for four weeks at the starting dose is a real price. If the $119 headline is what brought you here, that number should not be the reason you stay: it is the sixth of a $714 contract, and the providers in this batch that publish genuine cancel-anytime monthly rungs are Trellis Vitality at $150, Auren Rx at $199 and The Edit at $209. Start from the ranked verdicts and from the research the rulings are built on instead.